Overview

A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and efficacy of GW679769 and paroxetine in subjects with Social Anxiety Disorder
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Casopitant
Paroxetine